Tag: Petrelintide

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Petrelintide

Obesity drug from Zealand shows potential in early trial | BioPharma Dive

Added to Collection on: 2024-06-20 20:58:31

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
GLP-1 receptor agonist
Cagrilintide/semaglutide
Semaglutide
Cagrilintide
Tirzepatide
Amylin
Novo Nordisk
Petrelintide
Glucagon-like peptide-1
Survodutide
Zealand Pharma

Click the tags to see associated articles and topics

View Article Details
NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand - Yahoo Finance

Added to Collection on: 2025-03-13 18:46:52

Tags for this article:

Peptide hormones
GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Pancreatic hormones
Intestinal hormones
Cagrilintide/semaglutide
Petrelintide
Anti-obesity medication
Semaglutide
Cagrilintide
Glucagon-like peptide-1
Amylin
Zealand Pharma

Click the tags to see associated articles and topics

View Article Details
Roche strikes $5.3 billion amylin deal | Nature Biotechnology

Added to Collection on: 2025-04-15 02:21:06

Tags for this article:

Peptide hormones
Pancreatic hormones
Intestinal hormones
GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Glucagon-like peptide-1
Amylin
Incretin
Semaglutide
Glucagon
Anti-obesity medication
Petrelintide
Zealand Pharma

Click the tags to see associated articles and topics

View Article Details
Roche moves obesity asset CT-388 into Phase III - European Biotechnology Magazine

Added to Collection on: 2025-09-22 19:54:11

Tags for this article:

Peptide hormones
GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Intestinal hormones
Lipopeptides
Petrelintide
Anti-obesity medication
Incretin
Glucagon-like peptide-1
CT-388
Tirzepatide
Semaglutide
Graham

Click the tags to see associated articles and topics

View Article Details
Roche Targets Top Spot In Weight Loss Drug Market - Benzinga

Added to Collection on: 2025-09-22 18:37:09

Tags for this article:

Antineoplastic drugs
Selective estrogen receptor degraders
GLP-1 receptor agonists
Hereditary cancers
Azetidines
Giredestrant
Everolimus
Roche
Petrelintide
Obesity
Anti-obesity medication
CT-388
Roche Holdings AG

Click the tags to see associated articles and topics

View Article Details
Book a Demo